Protagonist Therapeutics Inc (PTGX)
27.09
+1.32
(+5.12%)
USD |
NASDAQ |
May 08, 16:00
27.09
0.00 (0.00%)
After-Hours: 19:40
Protagonist Therapeutics Market Cap: 1.579B for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 1.502B |
| May 06, 2024 | 1.519B |
| May 03, 2024 | 1.520B |
| May 02, 2024 | 1.488B |
| May 01, 2024 | 1.490B |
| April 30, 2024 | 1.463B |
| April 29, 2024 | 1.490B |
| April 26, 2024 | 1.466B |
| April 25, 2024 | 1.437B |
| April 24, 2024 | 1.498B |
| April 23, 2024 | 1.565B |
| April 22, 2024 | 1.551B |
| April 19, 2024 | 1.492B |
| April 18, 2024 | 1.470B |
| April 17, 2024 | 1.490B |
| April 16, 2024 | 1.522B |
| April 15, 2024 | 1.549B |
| April 12, 2024 | 1.576B |
| April 11, 2024 | 1.612B |
| April 10, 2024 | 1.625B |
| April 09, 2024 | 1.698B |
| April 08, 2024 | 1.637B |
| April 05, 2024 | 1.632B |
| April 04, 2024 | 1.611B |
| April 03, 2024 | 1.636B |
| Date | Value |
|---|---|
| April 02, 2024 | 1.631B |
| April 01, 2024 | 1.648B |
| March 28, 2024 | 1.686B |
| March 27, 2024 | 1.660B |
| March 26, 2024 | 1.632B |
| March 25, 2024 | 1.625B |
| March 22, 2024 | 1.633B |
| March 21, 2024 | 1.652B |
| March 20, 2024 | 1.683B |
| March 19, 2024 | 1.679B |
| March 18, 2024 | 1.659B |
| March 15, 2024 | 1.689B |
| March 14, 2024 | 1.652B |
| March 13, 2024 | 1.760B |
| March 12, 2024 | 1.741B |
| March 11, 2024 | 1.755B |
| March 08, 2024 | 1.767B |
| March 07, 2024 | 1.800B |
| March 06, 2024 | 1.822B |
| March 05, 2024 | 1.804B |
| March 04, 2024 | 1.844B |
| March 01, 2024 | 1.874B |
| February 29, 2024 | 1.770B |
| February 28, 2024 | 1.773B |
| February 27, 2024 | 1.724B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
127.60M
Minimum
Dec 03 2019
2.363B
Maximum
Sep 01 2021
922.53M
Average
856.28M
Median
Market Cap Benchmarks
| Lifecore Biomedical Inc | 203.60M |
| SELLAS Life Sciences Group Inc | 72.02M |
| Akebia Therapeutics Inc | 293.43M |
| Immuneering Corp | 48.34M |
| Moderna Inc | 46.70B |
Market Cap Related Metrics
| Price to Book Value | 4.689 |
| Price | 27.09 |
| Earnings Yield | -5.50% |